comparemela.com
Latest Breaking News On - Jesper lange - Page 1 : comparemela.com
MC2 Therapeutics bags license rights for hidradenitis suppurativa drug
MC2 Therapeutics has acquired the exclusive licensing rights for Regranion’s RGRN-305, a new treatment for hidradenitis suppurativa (HS).
Berlin
Germany
Lars-iversen
Gautam-ghatnekar
Jesper-lange
Venereology-congress
European-academy-of-dermatology
European-academy
Markets-amp-regulations
Emerging-markets
License
Licensing-agreement
MC2 Therapeutics and Huadong to commercialize psoriasis cream in Greater China
Huadong has been granted exclusive rights in Greater China to develop and commercialize MC2’s drug, Wynzora Cream, for the treatment of plaque psoriasis.
China
Huadong
Guangdong
Liang-lu
Sichuan
Jesper-lange
Greater-china
Huadong-medicine
Markets-amp-regulations
Emerging-markets
Psoriasis
vimarsana © 2020. All Rights Reserved.